Recently, we had the opportunity to meet Dr. Diego Morita, study physician for the Orchestra Study, to talk about the study, the aim of the study, what the medication is designed to do, who qualifies, and how to get involved.
Watch our interview below.
the orchestra study
To download the transcript, click here.
What: The Orchestra Study is exploring the use of an investigational drug for men and women with early-stage Parkinson’s. Dr. Morita said, “We are trying to find out if the study drug, UCB0599, is able to slow down the progression of Parkinson’s disease” by preventing the abnormal clumping of alpha-synuclein that can cause cell death.
Qualifications: Participants must:
- Be 40-75 years old
- Have been diagnosed within two years of entry into the study
- Have experienced slowness of movement and muscle stiffness or rigidity and/or tremor or shaking
- Have only mild symptoms
Have not taken medications to treat symptoms of Parkinson’s and are not expected to need any such medication in the following six months
Length & Logistics: The study lasts 21 months. Overall participation in the Orchestra Study will include 13 visits at the clinic with the study doctor and the study team and three additional visits that may be done at the participant’s home.
Location: The study is being conducted in multiple centers in North America and Europe, and there will be approximately 450 participants contributing to the study.
Contact: Visit the study site to learn more, take their qualification form, and read their FAQs to determine if it may be a good fit for you. Also, if you know someone who may meet the qualifications, please share this post with them.